Prevention of Hepatitis C Virus (HCV) and HIV-1 Co-Infections
A collaborative project financed by the EC Framework Programme 7
Prevention of Hepatitis C Virus (HCV) and HIV-1 Co-Infections through induction of potent T cell responses using prime-boost viral vector vaccine regimens
1st February 2013 until 31 October 2017.
Work on Work Package 3 was delayed and has now started under the project name PEACHI03 (safety and immunogenicity of second generation viral vectored technology using ChAd3 and MVA, employing NSmut linked to the human MHC class II invariant chain, in both healthy subjects and HIV-positive patients).
The PEACHI project is comprised of seven Work Packages. Details of each Work Package can be found here.